Market Analysis and Insights: Global Oxycodone Hydrochloride Market

Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL) and is considered slightly soluble in alcohol (octanol water partition coefficient is 0.7).

Due to the COVID-19 pandemic, the global Oxycodone Hydrochloride market size is estimated to be worth US$ 396.3 million in 2022 and is forecast to a readjusted size of US$ 459.2 million by 2029 with a CAGR of 2.1% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Oxycodone Hydrochloride accounting for % of the Oxycodone Hydrochloride global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Tablet segment is altered to an % CAGR throughout this forecast period.

USA keeps the dominant place in both the production and consumption. According to International Narcotics Control Board, USA takes about 78% oxycodone prescription share. Globally, oxycodone hydrochloride producers are concentrated in USA, France and UK. Leading players in oxycodone hydrochloride industry are Mallinckrodt, Purdue Pharma, Noramco(Johnson & Johnson), Siegfried and Macfarlan Smith, etc. The top 5 got about 80% market shares.

Global Oxycodone Hydrochloride Scope and Market Size

The global Oxycodone Hydrochloride market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Oxycodone Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


Oxycodone Hydrochloride

Others


Segment by Application


Tablet

Oral Solution

Oral Capsule

Intravenous Fluid

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Mallinckrodt

Purdue Pharma

Noramco(Johnson & Johnson)

Siegfried

Cepia-Sanofi

Macfarlan Smith

Chattem Chemicals(Sun Pharma)

Temad